Dermatologicals in Uruguay

Due to climate change, Uruguay is experiencing warmer weather and an extended rainfall season during 2024. These weather conditions have resulted in a strong outbreak of the mosquito-spread virus, dengue fever, which will give extra strength to the category. As a result, antipruritics is becoming the best performing dermatological in 2024, which is led by Urufarma with Prurisedan, followed by Spefar with Cortifar. The category remains very active in terms of product innovation.

The Dermatologicals in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Dermatologicals market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.